You are here

neuropsychiatric

Do Karuna, Cerevel Deals Signal Renewed Neuropsychiatric Interest From Big Pharma?

BioSpace

Mon, 06/3/24 - 12:09 pm

Cerevel Therapeutics

neuropsychiatric

Engrail closes $157M series B, fueled by investors' renewed interest in neuropsychiatry

Fierce Biotech

Tue, 03/19/24 - 11:58 am

Engrail Therapeutics

neuropsychiatric

Neurocrine Hit with Back-to-Back Phase II Failures in Neuropsychiatry

BioSpace

Fri, 11/10/23 - 10:14 am

neuropsychiatric

clinical trials

focal onset seizures

major depressive disorder

Harmony Makes Rare Disease Play with Potential $200M Zynerba Buyout

BioSpace

Tue, 08/15/23 - 11:36 am

Harmony Biosciences

neuropsychiatric

Boehringer Ingelheim to surf with Melbourne-based biotech in $181M neuropsychiatric therapy deal

Fierce Biotech

Fri, 05/5/23 - 11:53 am

Boehringer Ingelheim

Kinoxis Therapeutics

neuropsychiatric

Sunovion pens $890M Otsuka pact for a clutch of neuropsychiatric drugs

Fierce Biotech

Thu, 09/30/21 - 10:52 am

neuropsychiatric